Results demonstrated that similar outcomes can be achieved by a human coach-based program and an AI-based program. Moreover, ...

I read with interest, the Article by Yichen Zhang and colleagues,1 which presents an important retrospective evaluation of ...

Boston Scientific (($BSX)) announced an update on their ongoing clinical study. Study Overview: The Patient Retrospective Outcomes (PRO) study, ...

In separate treatment trials, one for de novo coronary lesions and the other for in-stent restenosis, a sirolimus-eluting ...

Dr. Stacie Stephenson, Vice-Chairman of Gateway for Cancer Research, joins Gayle Guyardo, host of Bloom, to share updates on innovative clinical trials and how these are changing the future of ...

The Lundquist Institute is proud to announce that Dong Chang, MD, MS has been awarded a prestigious R01 grant from the ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting an observational study titled ‘Observational ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

A study volunteer receiving Intellia’s transthyretin amyloidosis treatment was hospitalized due to severe signs of liver ...

While Carter continues to visit UAB for regular checkups, she has now been cancer-free for over three years. She uses her ...

Intellia earlier this year reported a similar grade 4 liver enzyme elevation associated with the gene therapy nexiguran ...

| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...